Pharmacists News
- CMSC 2023 Ozanimod for Relapsing MS Shows Long-Term Safety, Efficacy
- EU Commission Allocates $1.3 Billion to Tackle Mental Health
- Eisai-Biogen Alzheimer's Drug Data Confirms Benefits: FDA
- Teva to Pay Nevada $193 Million Over Role in Opioid Epidemic
- What Are the Health Risks From Wildfire Smoke?
- Alert EU Approves Bimekizumab for PsA and AxSpA
- Is ChatGPT a Friend or Foe of Medical Publishing?
- Advances in HIV Vaccine Research Show Promise for Prevention
- Semaglutide Bests Liraglutide for Post-Surgery Weight Regain
- Widespread Carboplatin, Cisplatin Shortages: NCCN Survey
- Biosimilar Comparable to Aflibercept in Neovascular AMD
- EAS 2023 High Lp(a) Tied to Higher Coronary Plaque, Progression
- GSK's Cancer Drug Jemperli Gets File Acceptance From US FDA
- Lung Cancer Device Study Raises Concerns for Commercial Use
- Pilot to Begin in UK Amid Uncertainty Over Wegovy Launch
- Merck Sues US Government to Halt Medicare Drug Price Negotiation
- EU Regulators Back WHO's COVID Vaccine Update Recommendation
- EULAR 2023 Uricase-Based Gout Drug Meets Endpoints in Phase 3 Trials
- White House Vows an Improved Effort Against Drug Overdoses
- Should Antibiotic Treatment Be Used Toward the End of Life?